Use access key #2 to skip to page content.
$17.14 0.27 (1.60%)
10/10/2008 4:00 PM

Regeneron Pharmaceuticals, Inc. (REGN)

CAPS Rating:
*

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

View All Commentary (REGN)

Recs

0

Avatar digitaldad1 (39.20) Submitted: 1/22/08 5:11 PM : Outperform Start Price: $23.88 REGN Score: 2.14

Big Pharma now owns 19% at a recent cost of $26.00.
Regeneron shares in the eventual profits while having all the costs covered by payments from this company.
A anti cancer drug promise for tumors is resting on Regeneron and the recent headline says it all:
Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration

Report this Post Replies: 0 | Reply

Featured Broker Partners